甲动物中的微塑料对人类健康构成潜在风险:转移,降解,协同作用和新陈代谢
Huibin Chen1,2, Xiaona Shen1,2, Jingying Lin1,2
1College of Life Science, Fujian Normal University, Fuzhou, China.
Critical reviews in food science and nutrition
|July 31, 2025
概括
微/纳米塑料 (MNP) 构成生态和人类健康风险,甲类动物作为关键指标. 值得注意的是,南极将微塑料转化为纳米塑料,增加了MNP危险.
科学领域:
- 环境毒理学环境毒理学
- 生态毒理学 生态毒理学
- 食物链的动态 食物链的动态
背景情况:
- 微/纳米塑料 (MNP) 是普遍存在的环境污染物.
- 甲类动物容易受到MNP的摄入和生物积累.
- 了解MNP生物转化和毒性对于风险评估至关重要.
研究的目的:
- 审查MNP生物转化机制和甲类动物的生态健康风险.
- 识别MNP生物降解和相关危害的知识差距.
- 评估MNP的转移及其通过食物链对人类的毒性影响.
主要方法:
- 文献综述综合了关于甲类的MNP现有研究.
- 对MNP代谢途径,毒性和生态影响的分析.
- 检查MNP与环境污染物和食物链转移的相互作用.
主要成果:
- 在甲类动物中存在MNP,其毒性受代谢途径的影响.
- 海洋污染物和共同污染物的联合毒性增加了通过海产品对人类健康的风险.
- 在南极的消化系统中,微塑料转化为纳米塑料的第一个证据.
结论:
- 甲类动物作为MNP风险评估的重要生态毒理学哨兵.
- 甲类的MNP生物转化,特别是MPs转化为NP,加剧了生态和健康方面的担忧.
- 需要对MNP-肠道微生物群相互作用以及生物分子在MNP代谢中的作用进行进一步的研究.
相关概念视频
Types of Toxins
2.0K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.0K
Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
377
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
377
Environmental Applications of Microorganisms
260
Microorganisms play a pivotal role in maintaining ecosystem balance by recycling essential elements such as carbon, nitrogen, and phosphorus, as well as supporting processes like bioremediation, wastewater treatment, and biofuel production.Microbes in Elemental CyclesIn the carbon cycle, microorganisms decompose organic matter, releasing carbon dioxide via aerobic respiration. This carbon dioxide is subsequently used by photosynthetic organisms to synthesize organic compounds, closing the...
260
Factors Affecting Drug Biotransformation: Biological
241
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
241


